We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+12.39%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
–
AUM
$1.62B
AUM Growth
+$99.5M
Cap. Flow
-$24.9M
Cap. Flow %
-1.54%
Top 10 Hldgs %
17.08%
Holding
826
New
61
Increased
333
Reduced
360
Closed
60

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$7.48M
2
KTF
DWS Municipal Income Trust
KTF
+$2.67M
3
NKX icon
Nuveen California AMT-Free Quality Municipal Income Fund
NKX
+$2.27M
4
NAD icon
Nuveen Quality Municipal Income Fund
NAD
+$2.16M
5
NAC icon
Nuveen California Quality Municipal Income Fund
NAC
+$2.14M

Top Sells

Rank Stock Value
1
GBT
Global Blood Therapeutics, Inc.
GBT
+$8.48M
2
NZF icon
Nuveen Municipal Credit Income Fund
NZF
+$7.27M
3
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$6.45M
4
MHD icon
BlackRock MuniHoldings Fund
MHD
+$4.26M
5
UNG icon
United States Natural Gas Fund
UNG
+$4.22M

Sector Composition

Rank Sector Weight
1 Healthcare 13.55%
2 Financials 10.66%
3 Technology 7.84%
4 Industrials 5.77%
5 Consumer Staples 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGNX icon
426
Cognex
CGNX
$10.6B
$675K 0.04%
14,322
+2,513
+21% +$118K
CHKP icon
427
Check Point Software Technologies
CHKP
$13.2B
$671K 0.04%
5,316
-37
-0.7% -$4.62K
MCHB
428
Mechanics Bancorp
MCHB
$3.8B
$671K 0.04%
24,315
+219
+0.9% +$5.99K
AVXL icon
429
Anavex Life Sciences
AVXL
$325M
$669K 0.04%
72,216
+5,757
+9% +$61.5K
MUB icon
430
iShares National Muni Bond ETF
MUB
$45.8B
$669K 0.04%
6,339
+43
+0.7% +$4.48K
PHAT icon
431
Phathom Pharmaceuticals
PHAT
$688M
$667K 0.04%
59,406
+4,735
+9% +$48.8K
VIR icon
432
Vir Biotechnology
VIR
$1.51B
$664K 0.04%
+26,215
New +$643K
UFPT icon
433
UFP Technologies
UFPT
$2.49B
$662K 0.04%
5,615
+805
+17% +$85.8K
BBAG icon
434
JPMorgan BetaBuilders US Aggregate Bond ETF
BBAG
$995M
$660K 0.04%
14,423
-399
-3% -$18.2K
AVY icon
435
Avery Dennison
AVY
$13.6B
$655K 0.04%
3,619
-443
-11% -$78.9K
AGIO icon
436
Agios Pharmaceuticals
AGIO
$1.95B
$654K 0.04%
23,297
+2,944
+14% +$83K
ETX
437
Eaton Vance Municipal Income 2028 Term Trust
ETX
$199M
$654K 0.04%
36,670
-1,108
-3% -$20.6K
JPC icon
438
Nuveen Preferred & Income Opportunities Fund
JPC
$2.91B
$653K 0.04%
89,708
+12,923
+17% +$93.7K
SWTX
439
DELISTED
SpringWorks Therapeutics
SWTX
$653K 0.04%
+25,118
New +$619K
MCY icon
440
Mercury Insurance
MCY
$5.86B
$652K 0.04%
19,051
-2,122
-10% -$70.6K
AWK icon
441
American Water Works
AWK
$27B
$644K 0.04%
4,223
-7,500
-64% -$1.08M
CMS icon
442
CMS Energy
CMS
$21.8B
$642K 0.04%
10,139
-2,725
-21% -$161K
KURA icon
443
Kura Oncology
KURA
$882M
$640K 0.04%
51,580
+6,430
+14% +$93.5K
FDX icon
444
FedEx
FDX
$76.3B
$637K 0.04%
3,678
+1,595
+77% +$265K
STX icon
445
Seagate
STX
$186B
$637K 0.04%
12,117
-596
-5% -$31.7K
WFC icon
446
Wells Fargo
WFC
$264B
$631K 0.04%
15,273
-734
-5% -$32.5K
EFX icon
447
Equifax
EFX
$21.4B
$630K 0.04%
3,243
+674
+26% +$123K
INTC icon
448
Intel
INTC
$493B
$630K 0.04%
23,828
+11,745
+97% +$326K
HBNC icon
449
Horizon Bancorp
HBNC
$1.05B
$629K 0.04%
41,702
+1,153
+3% +$19K
AMLX icon
450
Amylyx Pharmaceuticals
AMLX
$2.63B
$627K 0.04%
+16,956
New +$602K
16 17
18
19 20

Similar funds

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $3.48B AUM 24.9% 1-Year Est. Return
MSC
MUFG Securities (Canada) New York $3.48B AUM 45.13% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return

Hennion & Walsh Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Hennion & Walsh Asset Management held 826 positions worth $1.62B, up 6.5% from $1.52B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Hennion & Walsh Asset Management's Q4 2022 filing shows 61 new, 333 increased, 360 reduced and 60 closed positions. Its largest new stake was ConocoPhillips: 5,945 shares worth $702K. The largest sale was Global Blood Therapeutics, Inc., an estimated $8.48M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Financials and Technology.

  • Hennion & Walsh Asset Management's largest Q4 2022 buy was ConocoPhillips: 5,945 shares worth $702K.
  • Hennion & Walsh Asset Management added most to iShares Core S&P 500 ETF in Q4 2022, an estimated $7.48M increase.
  • Hennion & Walsh Asset Management's biggest Q4 2022 reduction was Nuveen Municipal Credit Income Fund, cutting an estimated $7.27M.
  • Hennion & Walsh Asset Management fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $8.48M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 17% of its $1.62B portfolio in Q4 2022.
  • Hennion & Walsh Asset Management opened 61 new positions and closed 60 in Q4 2022.
  • Hennion & Walsh Asset Management's portfolio value rose 6.5% quarter-over-quarter to $1.62B.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.